Author: Peggy G. Alanis

Most people are already familiar with CBD, the famous new cannabinoid on the market. However, cannabigerol (CBG) is another intriguing non-psychoactive cannabinoid obtained from the hemp herb. The two most commonly used cannabinoids include THC and CBD. Most marijuana genotypes only comprise small concentrations of CBG—roughly 1%—however, users and medical practitioners are interested in its benefits. Studies have shown that CBG has a therapeutic impact on some biological systems within the body and bears good prospects as a potential remedy for a wide array of severe or life-threatening illnesses and ailments. Nevertheless, before delving into the medicinal gains it might…

Read More